Fresenius Medical Care AG & Co. KGaA (FME:XETRA) Stock Forecast
Alert
Its only available to paid users.
N/A
Based on the Fresenius Medical Care AG & Co. KGaA stock forecast from 0 analysts, the average analyst target price for Fresenius Medical Care AG & Co. KGaA is not available over the next 12 months. Fresenius Medical Care AG & Co. KGaA’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Fresenius Medical Care AG & Co. KGaA is Bullish , which is based on 7 positive signals and 1 negative signals. At the last closing, Fresenius Medical Care AG & Co. KGaA’s stock price was EUR 39.90. Fresenius Medical Care AG & Co. KGaA’s stock price has changed by +14.03% over the past week, +15.28% over the past month and -5.70% over the last year.
No recent analyst target price found for Fresenius Medical Care AG & Co. KGaA
No recent average analyst rating found for Fresenius Medical Care AG & Co. KGaA
Company Overview Fresenius Medical Care AG & Co. KGaA
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany. Address: Else-KrOener-Strasse 1, Bad Homburg, Germany, 61352 Read Less
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clini...Read More
Frequently Asked Questions About Fresenius Medical Care AG & Co. KGaA (FME:XETRA) Stock
Stock Target Advisor's fundamental analysis for Fresenius Medical Care AG & Co. KGaA's stock is Bullish .
FME:XETRA stock's dividend yield is 3.05%.
Our analysis grades FME:XETRA stock's dividend yield at D+. This means that FME:XETRA stock's dividend yield is above 67% of the stocks in the Medical Care Facilities sector in the XETRA exchange.
Based on this FME:XETRA may be a average dividend stock for its sector.
Unfortunately we do not have enough data on FME:XETRA's stock to indicate what its average analyst target is.
FME:XETRA stock's Price/Earning ratio is 23.47.
Our analysis grades FME:XETRA stock's Price / Earning ratio at B. This means that FME:XETRA stock's Price/Earning ratio is above 14% of the stocks in the Medical Care Facilities sector in the XETRA exchange.
Based on this FME:XETRA may be undervalued for its sector.
The last closing price of FME:XETRA's stock was EUR 39.90.
The most recent market capitalization for FME:XETRA is EUR 11.71B.
Unfortunately we do not have enough analyst data on FME:XETRA's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Fresenius Medical Care AG & Co. KGaA's stock.
As per our most recent records Fresenius Medical Care AG & Co. KGaA has 119,845 Employees.
Fresenius Medical Care AG & Co. KGaA's registered address is Else-KrOener Strasse 1, Bad Homburg, Germany, 61352.
You can get more information about it from Fresenius Medical Care AG & Co. KGaA's website at https://www.freseniusmedicalcare.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior total returns
The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for FME:XETRA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
